featured
Association of Immune-Related Adverse Events With Survival Among Patients With Metastatic Melanoma Receiving Single-Agent or Combination Immunotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Network Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Association of Immune-Related Adverse Events, Hospitalization, and Therapy Resumption With Survival Among Patients With Metastatic Melanoma Receiving Single-Agent or Combination Immunotherapy
JAMA Netw Open 2022 Dec 08;5(12)e2245596, AS Watson, S Goutam, I Stukalin, BW Ewanchuk, M Sander, DE Meyers, A Pabani, WY Cheung, DYC Heng, T Cheng, JG Monzon, V NavaniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.